 NEW HAVEN, Conn., April 26, 2022 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. Nasdaq: BTAI, a commercial-stage biopharmaceutical company utilizing artificial intelligence AI approaches to identify and develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2022 financial results on Monday, May 9, 2022 before the open of the U.S. financial markets. BioXcel Therapeutics management team will also host a conference call and webcast at 8:30 AM ET to discuss the Companys financial results and to provide a general business update. 